Skip to content
AI IntelligenceApr 28, 2026Primary Market
Article

寻明生科 (Aureka Biotechnologies) · $35M · A+

Aureka Biotechnologies completed a $35M Series A+ round for AI-powered antibody drug discovery.

AI-generated: summaries written by AI from the linked sources. How we use AI

AI-generatedSource: 36Kr
01

Source Brief

Aureka Biotechnologies completed a $35M Series A+ round for AI-powered antibody drug discovery.